(Q34341665)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

review article

1 reference

title

Status of current clinical trials in diabetic polyneuropathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

V Bril

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 August 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

Canadian Journal of Neurological Sciences

10 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

191-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Diabetic neuropathy in elderly Type 2 diabetic patients: effects of insulin treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

A systematic review of antidepressants in neuropathic pain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Mexiletine in the Symptomatic Treatment of Diabetic Peripheral Neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

The US prevalence of self-reported carpal tunnel syndrome: 1988 National Health Interview Survey data

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effect of 24 weeks of treatment with epalrestat, an aldose reductase inhibitor, on peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effect of insulin and statil on aldose reductase expression in diabetic rats

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

The sorbinil retinopathy trial: neuropathy results. Sorbinil Retinopathy Trial Research Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Topical Capsaicin in Painful Diabetic Neuropathy: Controlled Study With Long-Term Follow-Up

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Mexiletine in the treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Pharmacologic treatment of pain in polyneuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Diabetic neuropathy: pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy. The Tolrestat Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Simple screening tests for peripheral neuropathy in the diabetes clinic.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Pentoxifylline in the treatment of distal diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Neuropathic pain of peripheral origin: advances in pharmacologic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Prosaposin gene expression and the efficacy of a prosaposin-derived peptide in preventing structural and functional disorders of peripheral nerve in diabetic rats

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Long-term effects of pancreatic transplantation on diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Treatment of diabetic neuropathy with inhibitors of the aldose reductase enzyme

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Report and recommendations of the San Antonio conference on diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Electrophysiological monitoring in clinical trials. Roche Neuropathy Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Lack of effect of clonidine and pentoxifylline in short-term therapy of diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Antihypoxic treatment at an early stage of diabetic neuropathy: an electrophysiological study with sabeluzole

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Human studies of recombinant human nerve growth factor and diabetic peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Neurotrophic factors in the therapy of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Mexiletine. A review of its therapeutic use in painful diabetic neuropathy.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Diabetes and the nervous system

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Diabetic neuropathies: features and mechanisms.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Identification of prosaposin as a neurotrophic factor

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Treatment of diabetic autonomic neuropathy with an aldose reductase inhibitor

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Anticonvulsants (antineuropathics) for neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

Diabetic peripheral neuropathy: nerve conduction studies before, during and after carbamazepine therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100001335

7 January 2021

10.1017/S0317167100001335

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11513337%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference